Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Transplant

Comparing Single-Center Outcomes Between Reference and Biosimilar Granulocyte Colony-Stimulating Factor Drugs Used for Autologous Stem-Cell Mobilization

Trace Bartels, PharmD; Molly Klanderman, PhD, MS; Jaime Rogers, MSN, RN; Kristin Gray, MSN, RN; Heidi Kosiorek, MS; Chris Coughlin, PharmD, BCOP

Impact of Letermovir for Cytomegalovirus Prophylaxis in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Brianna Archambeau, PharmD, BCOP; Ashley M. Leece, PharmD, BCOP, BCPS; Dhaval Patel, PharmD, BCOP; Chin Y. Liu, MS, PharmD, BCOP

Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant

Katelyn A. Zink, PharmD, BCOP; Jill Stein, PharmD, BCOP; Patrick Ten Eyck, MS, PhD; Meredith Ginn, PharmD, BCOP

Myeloablative and Reduced-Intensity Preparative Regimens for Allogeneic Transplant in the Outpatient versus Inpatient Setting in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Gretchen Pardo, PharmD; Beth Eddy, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Dennis Grauer, PhD, MS; Joseph P. McGuirk, DO

Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation

Jiyeon Joy Park, PharmD, BCOP; Esther Huang, PharmD, BCPS, BCOP; Colleen Ciccosanti, DO, MPH

Comparing Cyclophosphamide-Based versus Etoposide-Based Chemomobilization for Autologous Hematopoietic-Cell Transplant in Patients with Lymphoma

Taylor Dennison, PharmD; Zachary Pedretti, PharmD; Jing Zhu, PharmD; Kurtis Stocker, PharmD; Ryan Shaw, PharmD; Tatjana Grgic, PharmD; Maurice Alexander, PharmD; Marcie Riches, MD, MS; Hillary Heiling, BS; Jonathan Ptachcinski, PharmD

Sitagliptin, a DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant

Electrolyte Abnormalities and the Associated Risk for Atrial Fibrillation After Autologous Hematopoietic Stem-Cell Transplant

Natalie Schulze, PharmD; Kyle LaPorte, PharmD; Carol Breikreutz, PharmD, BCOP; Tobias Meissner, PhD; R. Vinod Parameswaran, MD, FRCPath, MRCP; Renju Raj, MD; Kelly McCaul, MD, ABIM, FRCPC

Vaccination Rates in Patients with Hematologic Cancers After Hematopoietic Stem-Cell Transplant: A Single-Center Retrospective Study

Hiba Ahmad, PharmD, BCOP; Sarah Perreault, PharmD, BCPS, BCOP; Dayna McManus, PharmD, BCPS-AQ ID; Francine Foss, MD; Iris Isufi, MD; Stuart Seropian, MD; Jeffrey Topal, MD

Horsies and Bunnies: Comparing Antithymocyte Globulin Drugs in Patients Undergoing Allogeneic Stem-Cell Transplant

Crystal Lu, PharmD, BCOP; Nancy Mikulandric, PharmD, BCOP; Meredith Grycki, PharmD, BCOP, BCPS; Vishnuprabha Vogel, PharmD, BCOP, BCPS; Shatha Farhan, MD; Edward Peres, MD; Nalini Janakiraman, MD; Klodiana Neme, PharmD, BCOP

Page 1 of 2
Results 1 - 10 of 15